Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drugHao Wu, Fredrik Bäckhed, Eduardo Esteve et al.|Nature Medicine|2017Cited by 1.6k
Definition and diagnostic criteria of clinical obesityFrancesco Rubino, An Pan, Louise A. Baur et al.|The Lancet Diabetes & Endocrinology|2025Cited by 1.3k
Insulin Resistance and Chronic Cardiovascular Inflammatory SyndromeJosé Manuel Fernández‐Real, Wifredo Ricart|Endocrine Reviews|2003Cited by 876
Physiology and role of irisin in glucose homeostasisNikolaos Perakakis, Christos S. Mantzoros, G. Triantafyllou et al.|Nature Reviews Endocrinology|2017Cited by 633
Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular eventsKonstantinos N. Aronis, Christos S. Mantzoros, José María Moreno‐Navarrete et al.|International Journal of Obesity|2014Cited by 111